Positron Imaging Tomography for Novel Applications
Legal Citation
Summary of the Inventive Concept
Expanding the core technology of positron imaging tomography imaging agent composition to detect bacterial contamination in various industries, including food, agriculture, water treatment, medical devices, and pharmaceutical manufacturing.
Background and Problem Solved
The original patent focused on treating bacterial infections in humans, but the diagnostic capabilities of positron imaging tomography can be applied to other industries where bacterial contamination is a significant concern. The new inventive concept addresses the limitations of current detection methods in these industries, providing a more accurate and efficient way to identify bacterial contamination.
Detailed Description of the Inventive Concept
The new inventive concept involves applying the positron imaging tomography imaging agent composition to various industries, including food, agriculture, water treatment, medical devices, and pharmaceutical manufacturing. The composition is used to detect bacterial contamination in these industries, enabling more accurate and efficient identification of contaminated products or systems. The new claims describe specific applications, such as monitoring food spoilage, detecting bacterial contamination in agricultural products, and identifying contamination in water treatment systems, medical devices, and pharmaceutical manufacturing processes.
Novelty and Inventive Step
The new claims introduce novel applications of the positron imaging tomography imaging agent composition, expanding its use beyond human bacterial infections to other industries. The inventive step lies in recognizing the potential of this technology to address bacterial contamination in various fields, and adapting the composition and detection methods to suit these new applications.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include modifying the composition or detection methods to accommodate specific industry requirements, such as adjusting the ratio of 4-amino-2-[18F]-fluorobenzoic acid to 4-amino-2-[19F]-fluorobenzoic acid or using different positron imaging tomography scanning protocols. Variations could also involve integrating the positron imaging tomography technology with existing detection methods or systems to enhance their accuracy and efficiency.
Potential Commercial Applications and Market
The new inventive concept has significant commercial potential in various industries, including food safety, agriculture, water treatment, medical devices, and pharmaceutical manufacturing. The market demand for more accurate and efficient bacterial contamination detection methods is high, and the positron imaging tomography technology could provide a competitive advantage in these industries.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B6/037 |
| A | A61 | A61K51/0402 |
| A | A61 | A61P31/04 |
| C | C07 | C07B59/001 |
| C | C07 | C07C227/12 |
| C | C07 | C07C229/60 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical imaging, radiopharmaceutical composition, and bacterial detection technologies involving positron emission tomography (PET) with specific focus on fluorinated imaging agents and diagnostic methodologies
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in radiochemistry, nuclear medicine, or biomedical engineering, possessing expertise in radioisotope synthesis, medical imaging techniques, and bacterial detection methodologies
Obviousness Rationale
A PHOSITA would recognize that extending the source patent's bacterial infection imaging technique to broader industrial applications represents a logical and predictable technological progression. The core imaging composition remains substantially unchanged, with the primary innovation being the identification of alternative detection contexts. The technical principles of positron imaging tomography are fundamentally transferable across different contamination detection scenarios, making the PTD's variations obvious extensions of the original patent's core technological concept.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,352 |
|---|---|
| Title | Positron imaging tomography imaging agent composition and method for bacterial infection |
| Assignee(s) | The Research Foundation for The State of University New York |